Dual antiplatelet therapy and the risk of bleeding

Archives of Internal Medicine

Volumn 171, Issue 8, 2011, Pages 787-

  Ziegelstein, Roy C ^a   Green, Ariel ^a   Sauder, Michael ^a  

^a JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; WARFARIN; ANTICOAGULANT AGENT; HEPARIN; IRBESARTAN; ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE; TICLOPIDINE;

ANTICOAGULANT THERAPY; BLEEDING; DEEP VEIN THROMBOSIS; HEART ATRIUM FIBRILLATION; HUMAN; LETTER; LUNG EMBOLISM; PATIENT SAFETY; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT; STROKE; TREATMENT DURATION; VASCULAR DISEASE; DRUG ELUTING STENT; DUAL ANTIPLATELET THERAPY; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; NOTE; RISK FACTOR; THROMBOSIS;

ASPIRIN; ATRIAL FIBRILLATION; DRUG THERAPY, COMBINATION; DRUG-ELUTING STENTS; HEMORRHAGE; HUMANS; PLATELET AGGREGATION INHIBITORS; RISK ASSESSMENT; RISK FACTORS; THROMBOSIS; TICLOPIDINE; WARFARIN;

EID: 79955772723     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Hansen ML, Sørensen R, Clausen MT, et al. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Arch Intern Med. 2010;170(16):1433-1441.
2. Connolly S, Pogue J, Hart R, et al; ACTIVE Writing Group of the ACTIVE Investigators. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet. 2006;367(9526):1903-1912.
3. King SB III, Smith SC Jr, Hirshfeld JW Jr, et al; 2005 Writing Committee Members. 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee. Circulation. 2008;117(2):261-295.
4. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ; American College of Chest Physicians. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6)(suppl):454S-545S.
5. The Joint Commission. Accreditation program: hospital: national patient safety goals: effective January 1, 2011. http://www.jointcommission.org/assets/1/6/2011_NPSGs_HAP.pdf. Accessed March 5, 2011.